Chugai OTC Stock Today

CHGCF -  USA Stock  

USD 27.57  0.00  0.00%

Market Performance
0 of 100
Odds Of Distress
Less than 44
Chugai Pharmaceutical is trading at 27.57 as of the 24th of May 2022, a No Change since the beginning of the trading day. The stock's lowest day price was 27.57. Chugai Pharmaceutical has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Chugai Pharmaceutical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of April 2022 and ending today, the 24th of May 2022. Click here to learn more.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. The company has 1.64 B outstanding shares. More on Chugai Pharmaceutical
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Chugai Pharmaceutical OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Chugai Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Chugai Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chugai Pharmaceutical generated a negative expected return over the last 90 days
About 60.0% of the company shares are held by company insiders
Latest headline from www.smartkarma.com: Health Care Virtus Health, Yunkang Group, Aier Eye Hospital Group, Chugai Pharmaceutical, Eris Lifesciences, Glaxosmithkline Pharmaceuticals and more - Smartkarma
Chairman and CEOOsamu Nagayama  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Chugai Pharmaceutical's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Chugai Pharmaceutical [CHGCF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Large-Cap' category with current market capitalization of 45.51 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chugai Pharmaceutical's market, we take the total number of its shares issued and multiply it by Chugai Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Chugai Pharmaceutical classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.64 B outstanding shares. Chugai Pharmaceutical has accumulated about 431.82 B in cash with 409.3 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 262.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Chugai Pharmaceutical Probability Of Bankruptcy
Ownership
Chugai Pharmaceutical retains a total of 1.64 Billion outstanding shares. Chugai Pharmaceutical shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company outstanding shares. 60.17 percent of Chugai Pharmaceutical outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Chugai Ownership Details

Chugai Stock Price Odds Analysis

What are Chugai Pharmaceutical's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Chugai Pharmaceutical jumping above the current price in 90 days from now is about 98.0%. The Chugai Pharmaceutical probability density function shows the probability of Chugai Pharmaceutical otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Chugai Pharmaceutical has a beta of -0.1732 suggesting as returns on benchmark increase, returns on holding Chugai Pharmaceutical are expected to decrease at a much lower rate. During the bear market, however, Chugai Pharmaceutical is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Chugai Pharmaceutical is significantly underperforming DOW.
  Odds Below 27.57HorizonTargetOdds Above 27.57
1.57%90 days
 27.57 
98.41%
Based on a normal probability distribution, the odds of Chugai Pharmaceutical to move above the current price in 90 days from now is about 98.0 (This Chugai Pharmaceutical probability density function shows the probability of Chugai OTC Stock to fall within a particular range of prices over 90 days) .

Chugai Pharmaceutical Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Chugai Pharmaceutical market risk premium is the additional return an investor will receive from holding Chugai Pharmaceutical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Chugai Pharmaceutical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Chugai Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Chugai Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.

Chugai Stock Against Markets

Picking the right benchmark for Chugai Pharmaceutical otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Chugai Pharmaceutical otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Chugai Pharmaceutical is critical whether you are bullish or bearish towards Chugai Pharmaceutical at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chugai Pharmaceutical without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Chugai Pharmaceutical Corporate Directors

Chugai Pharmaceutical corporate directors refer to members of a Chugai Pharmaceutical board of directors. The board of directors generally takes responsibility for the Chugai Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Chugai Pharmaceutical's board members must vote for the resolution. The Chugai Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Masayuki Oku - Independent DirectorProfile
Franz Humer - Independent DirectorProfile
Sophie KornowskiBonnet - Independent DirectorProfile
Yasuo Ikeda - Independent DirectorProfile

Investing Chugai Pharmaceutical

You need to understand the risk of investing before taking a position in Chugai Pharmaceutical. The danger of trading Chugai Pharmaceutical is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Chugai Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Chugai Pharmaceutical. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Chugai Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Chugai OTC Stock analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Is Chugai Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chugai Pharmaceutical. If investors know Chugai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chugai Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chugai Pharmaceutical is measured differently than its book value, which is the value of Chugai that is recorded on the company's balance sheet. Investors also form their own opinion of Chugai Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Chugai Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chugai Pharmaceutical's market value can be influenced by many factors that don't directly affect Chugai Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.